Angiocrine Bioscience

Ms. Breneman is Senior Director, Project Management at Angiocrine Bioscience. Margie has over 20 years of experience leading teams in the medical device, pharmaceutical, and biotech companies. As QA Associate Director of Strategic Initiatives at Illumina, Margie led the Quality Systems Improvement Program to ensure compliance to ISO and FDA requirements for DNA sequencing products, including the MiSeqDx System, the first FDA approved device for in vitro diagnostic (IVD) testing. Margie also headed teams at Guidant and Abbott in areas of process improvement (Lean, Kaizen, 5S), facility design, cost reduction, software development, and technology transfer. In 2007, she received the Abbott Vascular President’s Award for the implementation of the CAMSTAR MES system to capture cGMP data for XIENCE, the market-leading drug-eluting stent. Margie has a degree in Industrial Engineering from California Polytechnic State University, San Luis Obispo, a professional certificate in Regulatory Affairs from San Diego State University, and is a certified Project Management Professional (PMP).

Angiocrine Bioscience's headquarters in San Diego, CA, United States

Org chart

Teams

Clinical Development Team

Offices